Full View

Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer

HL MacGregor, C Garcia-Batres, A Sayad, A Elia… - …, 2019 - Taylor & Francis
ABSTRACT B7-H4, an immune suppressive member of the B7 family, is highly expressed in
a wide variety of human malignancies making it an attractive immunotherapeutic target …
被引用次数：30 相关文章

Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer.

HL MacGregor, C Garcia-Batres, A Sayad, A Elia… - …, 2019 - europepmc.org
ABSTRACT B7-H4, an immune suppressive member of the B7 family, is highly expressed in
a wide variety of human malignancies making it an attractive immunotherapeutic target …

Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer

HL MacGregor, C Garcia-Batres, A Sayad… - …, 2019 - pubmed.ncbi.nlm.nih.gov
B7-H4, an immune suppressive member of the B7 family, is highly expressed in a wide
variety of human malignancies making it an attractive immunotherapeutic target. However …
[HTML] nih.gov

[HTML][HTML] Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian …

HL MacGregor, C Garcia-Batres, A Sayad, A Elia… - …, 2019 - ncbi.nlm.nih.gov
ABSTRACT B7-H4, an immune suppressive member of the B7 family, is highly expressed in
a wide variety of human malignancies making it an attractive immunotherapeutic target …

Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer.

HL MacGregor, C Garcia-Batres, A Sayad, A Elia… - …, 2019 - europepmc.org
ABSTRACT B7-H4, an immune suppressive member of the B7 family, is highly expressed in
a wide variety of human malignancies making it an attractive immunotherapeutic target …